Mozambique
2 Vaccines Approved for Use in Mozambique
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 140 countries
64 trials in 31 countries
Approval Source: allafrica.com
Inactivated
Sinopharm (Beijing)
Covilo
Approved in 91 countries
30 trials in 12 countries
Approval Source: herald.co.zw
2 in Clinical Trials in Mozambique
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 140 countries
64 trials in 31 countries
Inactivated
Sinopharm (Beijing)
Covilo
Approved in 91 countries
30 trials in 12 countries